SCHEMBL7540248

SCHEMBL7540248

COc1ccc(-c2ccc3cc(O)ccc3c2)cc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 4/20 0.76
ABCB1 P08183 4/20 0.76
BCR P11274 4/20 0.76
ESR2 Q92731 9/20 0.69
ESR1 P03372 8/20 0.69
NPC1 O15118 2/20 0.62
RAB9A P51151 2/20 0.62
TP53 P04637 1/20 0.62
MAPK1 P28482 1/20 0.62
CASP3 P42574 1/20 0.62
SMN1; SMN2 Q16637 1/20 0.62
SENP8 Q96LD8 1/20 0.62
SENP7 Q9BQF6 1/20 0.62
SENP6 Q9GZR1 1/20 0.62
FTO Q9C0B1 1/20 0.62
HSD17B1 P14061 2/20 0.57
HSD17B2 P37059 2/20 0.57
CYP1A2 P05177 1/20 0.57
CYP3A4 P08684 1/20 0.57
CYP2D6 P10635 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6899843 0.94 ABL1 (0.69) ABL1ABCB1BCRESR2ESR1
SCHEMBL14473526 0.88 ESR2 (0.69) ABL1ABCB1BCRESR2ESR1
SCHEMBL28147639 0.87 HSD17B1 (0.68) ABL1ABCB1BCRESR2NPC1
SCHEMBL31554258 0.83 ABL1 (0.62) ABL1ABCB1BCRESR2ESR1
SCHEMBL3020390 0.83 HSD17B1 (0.76) ABL1ABCB1BCRESR2NPC1
SCHEMBL547847 0.83 ABL1 (0.62) ABL1ABCB1BCRESR2ESR1
SCHEMBL28104773 0.83 HSD17B1 (0.63) ABL1ABCB1BCRESR2NPC1
SCHEMBL29869048 0.83 ABL1 (0.62) ABL1ABCB1BCRESR2ESR1
SCHEMBL1341494 0.83 ESR2 (1.00) ABL1ABCB1BCRESR2ESR1
SCHEMBL2699234 0.83 ESR1 (1.00) ABL1ABCB1BCRESR2ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6410754-B1 OPTIC LENSES (GLASSES, SUNGLASSES); HIGH COLORABILITY AND SENSITIVITY TO ACTIVATING IRRADIATION FLAMEL TECHNOLOGIES (FR) 2002-06-25 US disclosed
US-20020049341-A1 PHOTOCHROMIC SPIROPYRANS, AND COMPOSITIONS AND ARTICLES CONTAINING SAME FLAMEL TECHNOLOGIES (FR) 2002-04-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020049341-A1 PHOTOCHROMIC SPIROPYRANS, AND COMPOSITIONS AND ARTICLES CONTAINING SAME ALDH1A2, RB1, CRYAA ABL1 4767/4885ABCB1 1225/4885BCR 2777/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.